Nutritional issues in treating phenylketonuria

被引:50
作者
Feillet, Francois [1 ]
Agostoni, Carlo [2 ]
机构
[1] Hop Enfants, CHU Brabois, INSERM,U954, Ctr Reference Malad Hereditaires Metab Nancy, F-54500 Vandoeuvre Les Nancy, France
[2] Univ Milan, Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Dept Maternal & Pediat Sci, I-20122 Milan, Italy
关键词
POLYUNSATURATED FATTY-ACIDS; GLYCOGEN-STORAGE-DISEASE; FISH-OIL SUPPLEMENTATION; TOTAL ANTIOXIDANT STATUS; PLANNING VEGAN DIETS; BONE-MINERAL DENSITY; OXIDATIVE STRESS; PROTEIN SUBSTITUTE; INBORN-ERRORS; CHILDREN;
D O I
10.1007/s10545-010-9043-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A phenylalanine (Phe)-restricted diet is the mainstay of phenylketonuria (PKU) treatment, and, in recent years, the nutritional management of PKU has become more complex in order to optimize patients' growth, development and diet compliance. Dietary restriction of Phe creates a diet similar to a vegan diet, and many of the nutritional concerns and questions applicable to vegans who wish to avoid animal products are also relevant to patients with PKU. Owing to their nutritional characteristics, breast milk and breastfeeding should be given greater consideration as a useful food in patients with PKU and in those with other inborn errors of metabolism. Further key issues for consideration include the quality of the available amino acid substitutes, the neurotrophic and neuroprotective effects of added long-chain polyunsaturated fatty acids (e.g. docosahexaenoic acid), micronutrient deficiencies, bone disease and antioxidant status. Long-term dietary guidance and monitoring of the nutritional status of patients with PKU should be part of a follow-up programme that continues for life.
引用
收藏
页码:659 / 664
页数:6
相关论文
共 53 条
  • [31] Does a vegan diet reduce risk for Parkinson's disease?
    McCarty, MF
    [J]. MEDICAL HYPOTHESES, 2001, 57 (03) : 318 - 323
  • [32] Considerations in planning vegan diets: Children
    Messina, V
    Mangels, AR
    [J]. JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 2001, 101 (06) : 661 - 669
  • [33] Is deoxypyridinoline a good resorption marker to detect osteopenia in phenylketonuria?
    Millet, P
    Vilaseca, MA
    Valls, C
    Pérez-Dueñas, B
    Artuch, R
    Gómez, L
    Lambruschini, N
    Campistol, J
    [J]. CLINICAL BIOCHEMISTRY, 2005, 38 (12) : 1127 - 1132
  • [34] Peak bone mass in patients with phenylketonuria
    Modan-Moses, D.
    Vered, I.
    Schwartz, G.
    Anikster, Y.
    Abraham, S.
    Segev, R.
    Efrati, Ori
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 (02) : 202 - 208
  • [35] Lipid status and long-chain polyunsaturated fatty acid concentrations in adults and adolescents with phenylketonuria on phenylalanine-restricted diet
    Moseley, K
    Koch, R
    Moser, AB
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2002, 25 (01) : 56 - 64
  • [36] Porta F., 2008, J INHERIT METAB DIS
  • [37] Evidence of Oxidative Stress in Alzheimer's Disease Brain and Antioxidant Therapy Lights and Shadows
    Pratico, Domenico
    [J]. MITOCHONDRIA AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISORDERS, 2008, 1147 : 70 - 78
  • [38] Bone mineral density in children, adolescents and adults with glycogen storage disease type Ia: A cross-sectional and longitudinal study
    Rake, JP
    Visser, G
    Huismans, D
    Huitema, S
    van der Veer, E
    Piers, DA
    Smit, GPA
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2003, 26 (04) : 371 - 384
  • [39] Early breastfeeding is linked to higher intelligence quotient scores in dietary treated phenylketonuric children
    Riva, E
    Agostoni, C
    Biasucci, G
    Trojan, S
    Luotti, D
    Fiori, L
    Giovannini, M
    [J]. ACTA PAEDIATRICA, 1996, 85 (01) : 56 - 58
  • [40] Acceptability of a new modular protein substitute for the dietary treatment of phenylketonuria
    Rohr, FJ
    Munier, AW
    Levy, HL
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2001, 24 (06) : 623 - 630